Navigation Links
Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs

ST. PAUL, Minn., Oct. 10, 2011 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, has met high standards of pharmacy cost transparency, earning its 2012 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) certification from the HR Policy Association. This is the fifth consecutive year Prime has received this certification.

TIPPS certification is given annually to pharmacy benefit managers (PBMs) that have agreed to provide pharmacy cost information to the association's 60 member companies, who purchase pharmacy benefits for more than five million Americans. Prime was one of just four PBMs that agreed to a set of comprehensive requirements for disclosure of supply costs and revenue sources, and also provided actual average inventory cost (AAIC) for mail service drugs, earning it the HR Policy Association's Tier One Certification for 2012.

"At Prime, we are committed to an approach that integrates medical and pharmacy as well as a philosophy of transparency," said Eric Elliott, president and chief executive officer of Prime. "TIPPS certification continues to be an important recognition for Prime, and we believe that aligning with our clients at mail as well as retail demonstrates our intent to deliver the lowest possible cost of care for clients and their members."

The TIPPS program requires PBMs to provide transparency in reporting acquisition costs, home delivery costs, pass-through of pharmacy revenue, specialty pharmacy drug costs, plan management and consumer engagement efforts. Participating PBMs also grant the association the right to audit the organization in each of these areas. The program's standards promote contracting that makes it easier for employers, their beneficiaries and dependents to understand the true price of a drug and highlight the true value PBMs bring to health care.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics Launches CareCentered Contracting™ Program
2. Wasatch Pediatrics Selects Phreesia and Greenway PrimeSUITE to Streamline its Workflow and Increase Cash Flow
3. Greenways Remote Clinic PrimeMOBILE Available on Apples iPad
4. Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry
5. PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA
6. Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per Prescription
7. Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
8. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
9. Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement
10. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
11. TriLink BioTechnologies, Inc. Awarded European Patent for CleanAmp™ Primers
Post Your Comments:
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):